Abbonarsi

Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction - 27/07/22

Doi : 10.1016/j.diabet.2022.101349 
Pil Sang Song a, , 1 , Kye Taek Ahn a, 1, Mi Joo Kim a, Seok-Woo Seong a, Si Wan Choi a, Hyeon-Cheol Gwon b, Seung-Ho Hur c, Seung-Woon Rha d, Chang-Hwan Yoon e, Myung Ho Jeong f, Jin-Ok Jeong a,

KAMIR-NIH Investigators

a Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Republic of Korea 
b Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea 
c Keimyung University Dongsan Medical Center, Cardiovascular Medicine, Deagu, Republic of Korea 
d Cardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea 
e Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea 
f Chonnam National University Hospital, Gwangju, Republic of Korea 

Corresponding authors at: Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea.Division of Cardiology, Department of Internal MedicineChungnam National University Hospital, Chungnam National University College of Medicine282 Munhwa-ro, Jung-guDaejeon35015Republic of Korea

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

Diabetes mellitus (DM) is highly prevalent among individuals hospitalized with acute myocardial infarction (AMI) and is associated with increased risk for long-term mortality.
ü
DM is highly prevalent among individuals hospitalized with AMI and is associated with increased risk for long-term mortality.
Over a median follow-up of three years, diabetes was associated with a 32% higher all-cause mortality after adjusting for multiple covariates in the entire cohort.
ü
DM was associated with a 32% higher all-cause mortality after adjusting for multiple covariates in the entire cohort.
These findings highlight the need for more aggressive therapies aimed at preventing future adverse cardiovascular events in young patients post-AMI.
ü
These findings highlight the need for more aggressive therapies aimed at preventing future adverse cardiovascular events in young patients post-AMI.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Aim

To test the hypothesis that the impact of diabetes mellitus on clinical outcomes after acute myocardial infarction (AMI) can vary by age.

Methods

A total of 12,600 AMI patients from the Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) between November 2011 and December 2015 was classified into young (n = 3,590 [29%]) and old (n = 9,010 [72%]). Those less than 55 years of age were considered young. We performed comparisons of baseline characteristics, in-hospital treatments, and 3-year clinical outcomes between patients with and without diabetes after stratification according to age group.

Results

The prevalence of diabetes mellitus was 27% in the young AMI group. In the multivariable adjusted model of the entire cohort, diabetes mellitus was associated strongly with 3-year all-cause mortality (13% vs. 6.8%; adjusted hazard ratio [HR], 1.318; 95% confidence interval [CI], 1.138–1.526; P<0.001). When the entire cohort was subdivided into two age groups, young diabetic patients showed a 107% higher mortality rate than those without diabetes (adjusted HR, 2.07 [1.153.72]; P = 0.015). Meanwhile, old diabetic patients had a 25% higher risk of mortality than non-diabetic patients (adjusted HR, 1.25 [1.081.46]; P = 0.004). The interaction of diabetes with age was significant (adjusted P for interaction = 0.008).

Conclusions

Diabetes mellitus is not uncommon in younger AMI patients, and the relative risk of 3-year mortality is significantly higher in young patients than in older counterparts. More aggressive treatments are needed to prevent future cardiovascular events in younger patients after AMI.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Acute myocardial infarction, Diabetes mellitus, Age, Prognosis

List of abbreviations : AMI, CI, DM, HR, KAMIR-NIH, MACE, PCI, RAAS


Mappa


© 2022  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 48 - N° 4

Articolo 101349- luglio 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Epigenetic changes associated with hyperglycaemia exposure in the longitudinal D.E.S.I.R. cohort
  • Amna Khamis, Lijiao Ning, Beverley Balkau, Amélie Bonnefond, Mickaël Canouil, Ronan Roussel, Philippe Froguel
| Articolo seguente Articolo seguente
  • Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study
  • Anda-Petronela Radan, Mihaela-Madalina Fluri, Konstantinos Nirgianakis, Beatrice Mosimann, Bettina Schlatter, Luigi Raio, Daniel Surbek

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.